Christian Hinrichs, MD
Enriched profileChief of Cancer Immunotherapy, Rutgers Cancer Institute; Co-Director, Cancer Immunology and Metabolism Center of Excellence; Professor of Medicine, Rutgers Robert Wood Johnson Medical School · Rutgers Cancer Institute
Christian Hinrichs is Chief of Cancer Immunotherapy, Rutgers Cancer Institute; Co-Director, Cancer Immunology and Metabolism Center of Excellence; Professor of Medicine, Rutgers Robert Wood Johnson Medical School at Rutgers Cancer Institute. OpenAlex indexes 221 publications with 12,519 citations (h-index 41); ClinicalTrials.gov lists 7 registered studies with this person as an investigator.
Data verified 18 Oct 2026
Overview
Updated 25 Oct 2026
Christian Hinrichs, M.D., is Chief of Cancer Immunotherapy, Rutgers Cancer Institute. The public record shows 221 publications with 12,519 citations (h-index 41), centered on Immunotherapy and Immune Responses, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 2 companies.
- Most recent indexed publication: 2025 · Cancer immunology research
- Top research focus: Immunotherapy and Immune Responses
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 25 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 11 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 66.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 25 Oct 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Sponsor: Christian Hinrichs
- E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Sponsor: Christian Hinrichs
- KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
Sponsor: Christian Hinrichs
Industry payments
Updated 25 Oct 2026
2 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20241 payment$14,000openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20211 payment
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 25 Oct 2026
18 congress contributions (2014–2026) across AACR, ASCO, ASH per OpenAlex. The most recent:
- Abstract 617: OSTM1 is a ubiquitin E3 ligase that suppresses B-cell malignancy by activating the cAMP/PKA pathway.
AACR Annual Meeting
AACR2026Co-author - CD22 TCR-Engineered T Cells Exert Anti-Leukemia Cytotoxicity without Causing Inflammatory Responses
ASH Annual Meeting
ASH2023Co-author - A phase I trial of T-cell receptor gene therapy targeting KK-LC-1 for gastric, breast, cervical, lung and other KK-LC-1 positive epithelial cancers.
ASCO Annual Meeting
ASCO2022Co-authorPosterTrials in progress
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 25 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- GPC2-Targeted CAR T Cells Engineered with NFAT-Inducible Membrane-Tethered IL15/IL21 Exhibit Enhanced Activity against Neuroblastoma.
Cancer immunology research
Article2025 - Respiration defects limit serine synthesis required for lung cancer growth and survival.
Nature communications
Article2025 - CD22 TCR-engineered T cells exert antileukemia cytotoxicity without causing inflammatory responses.
Science advances
Article2025 - Cooperative Armoring of CAR and TCR T Cells by T Cell-Restricted IL15 and IL21 Universally Enhances Solid Tumor Efficacy.
Clinical cancer research
Article2024
Most-cited works
by citation count (OpenAlex)- 01Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial CancerArticle1,720 citations2014
- 02Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cellsArticle1,032 citations2009
- 03Tumor-specific Th17-polarized cells eradicate large established melanomaArticle845 citations2008
- 04Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and functionArticle727 citations2005
- 05
Network
Updated 25 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 25 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/christian-hinrichs-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
cinj.org/research/christian-s-hinrichs-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cinj.org ↗
Mentions by others
where others cite or feature them- Other
cinj.org/researcher-profiles
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cinj.org ↗ - Other
events.nyas.org/cancerio26/speaker/2248473/christian-hinrichs-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →events.nyas.org ↗ - Other
rwjbh.org/doctors/christian-s-hinrichs-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rwjbh.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 25 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
- Internal Medicine Residency
George Washington University
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →events.nyas.org ↗ - General Surgery Residency
University of Missouri–Kansas City
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →events.nyas.org ↗ - Surgical Oncology Fellowship
Roswell Park
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →events.nyas.org ↗ - Medical Oncology Fellowship
National Cancer Institute
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →events.nyas.org ↗ - Post-doctoral Tumor Immunology Fellowship
National Cancer Institute
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →events.nyas.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmwcintl.com ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →events.nyas.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Tina Mayer, MD
Rutgers Cancer Institute
Bo Qin
Rutgers Cancer Institute
Nicholas Denunzio, MD, PhD
Rutgers Cancer Institute
Lara Hathout
Rutgers Cancer Institute
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH